BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2016
View Archived Issues
New biomarkers in rheumatoid disease presented at ACR meeting
Read More
Arsanis' ASN-100 receives FDA fast track designation
Read More
ABC-1183, a novel GSK3/CDK9 inhibitor
Read More
EC grants orphan designation to Agilis Biotherapeutics' AGIL-AADC
Read More
AmorePacific initiates phase III trial of PAC-14028 in atopic dermatitis
Read More
Vertex initiates phase II study of VX-152 combination therapy for cystic fibrosis
Read More
A first-in-class small-molecule inhibitor of PD-L1 and TIM-3
Read More
Daiichi Sankyo's DS-8201 given FDA fast track designation
Read More
First phase Ia/b data for anti-RSPO3 antibody OMP-131R10 in advanced solid tumors
Read More
City of Hope and TGen form alliance to advance precision medicine
Read More
Axial Biotherapeutics launches with series A financing
Read More
Portage Biotech forms new ophthalmic-focused company
Read More
Kalyra Pharmaceuticals patents EGFR inhibitors
Read More
Wistar Institute discloses EBNA-1 inhibitors
Read More
GlaxoSmithKline describes RIP-1 kinase 1 inhibitors
Read More
Medshine Discovery develops PDE2A inhibitors and TNF-alpha production inhibitors
Read More
Kainos Medicine presents Brd4 inhibitors
Read More
Aequus BioPharma synthesizes melanocortin fusion peptide for treating gout
Read More
IONIS-ANGPTL3-LRx shows potential to reduce plasma ANGPTL3 and lipids
Read More
Ferring Pharmaceuticals and Ache Laboratorios Farmaceuticos form nanotechnology collaboration
Read More
Biophytis' Sarconeos safe in SARA-PK clinical study
Read More
Aradigm reports topline results from ORBIT-3 and -4 studies of Pulmaquin
Read More
Inovio Pharmaceuticals awarded grant for MAb against Zika virus
Read More
GALACTIC-HF phase III trial of omecamtiv mecarbil begins
Read More
HDAC6 inhibitor ACY-241 given U.S. orphan status for multiple myeloma
Read More
Dosing begins in phase I/II study of Agenus' INCAGN-1949
Read More
Shire's Cinryze granted U.S. orphan status for acute antibody-mediated renal transplant rejection
Read More